Last reviewed · How we verify
Intravenous infusion of transduced cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Intravenous infusion of transduced cells (Intravenous infusion of transduced cells) — Great Ormond Street Hospital for Children NHS Foundation Trust.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous infusion of transduced cells TARGET | Intravenous infusion of transduced cells | Great Ormond Street Hospital for Children NHS Foundation Trust | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous infusion of transduced cells CI watch — RSS
- Intravenous infusion of transduced cells CI watch — Atom
- Intravenous infusion of transduced cells CI watch — JSON
- Intravenous infusion of transduced cells alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous infusion of transduced cells — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-infusion-of-transduced-cells. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab